Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2014
03/26/2014CN103656606A Polypeptide colon-targeted drug delivery preparation and preparation method thereof
03/26/2014CN103655505A Pain relieving bilayer controlled-release tablet and preparation method thereof
03/26/2014CN103655475A Targeted liposomes
03/26/2014CN103655474A Compound drug-carrying liposome as well as preparation method and application thereof
03/26/2014CN103027897B Method for preparing monodispersity hydrophobic drug nanoparticles by template method
03/26/2014CN102688200B Plant anti-cancer targeting nano-preparation, and preparation method thereof
03/26/2014CN102232934B Pulsatile pellet, pulsatile orally disintegrating tablet containing same, and preparation methods and applications thereof
03/26/2014CN102164614B Use of an Ang-(1-7) receptor agonist in acute lung injury
03/25/2014US8680105 Method of treating down's syndrome
03/25/2014US8680104 Piperazinylpiperidine derivatives as chemokine receptor antagonists
03/25/2014US8680092 Nitrogenous heterocyclic compound and medicinal use thereof
03/25/2014US8680084 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
03/25/2014US8680074 Use of chitosans to increase nail growth rate
03/25/2014US8679506 Glucan-based vaccines
03/25/2014CA2753899C Polyalkylene glycol with moiety for conjugating biologically active compounds
03/25/2014CA2597395C Method and composition for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
03/25/2014CA2524610C Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
03/25/2014CA2484538C Vectors with modified protease-dependent tropism
03/25/2014CA2474011C Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders
03/25/2014CA2445826C Treatment and diagnosis of macrophage mediated disease
03/25/2014CA2434672C Sfrp and peptide motifs that interact with sfrp and methods of their use
03/25/2014CA2306492C Human checkpoint kinase, hcds1, compositions and methods
03/21/2014CA2790636A1 Treatment of hydrogel-dependent amyloid aggregation disease
03/20/2014WO2014043647A1 Therapeutic compositions and associated methods
03/20/2014WO2014042185A1 Screening method for medicines for treating inflammatory disease
03/20/2014WO2014042148A1 Cancer marker and application thereof
03/20/2014WO2014016548A3 Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient
03/20/2014WO2013192274A3 Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy
03/20/2014WO2013164512A3 Composition for use in the treatment and/or prevention of ocular inflammation, oxidative stress and neovascularization
03/20/2014US20140080892 Antisense modulation of fibroblast growth factor receptor 4 expression
03/20/2014US20140080890 Use of glycopyrrolate for treating tachycardia
03/20/2014US20140080886 Methods for Treating HCV
03/20/2014US20140080875 3,4-diaminopyridine tartrate and phosphate, pharmaceutical compositions and uses thereof
03/20/2014US20140080874 Methods For Treating Inflammation
03/20/2014US20140080869 Methods for Treating HCV
03/20/2014US20140080868 Methods for Treating HCV
03/20/2014US20140080867 Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators
03/20/2014US20140080861 Heterocyclic compounds iwth affinity to muscarinic receptors
03/20/2014US20140080856 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
03/20/2014US20140080849 Small Molecular Inhibitors of RAD51 Recombinase and Methods Thereof
03/20/2014US20140080841 Chemical Permeation Enhancers Enhance Nerve Blockade by Toxins
03/20/2014US20140080837 Sanglifehrin Derivatives and Methods for Their Production
03/20/2014US20140080836 Methods and compositions for treating or preventing erythema
03/20/2014US20140080835 Quinazolinone derivatives as parp inhibitors
03/20/2014US20140080828 Imidazolyl amide compounds and uses related thereto
03/20/2014US20140080827 Novel kinase modulators
03/20/2014US20140080815 Dosing regimen for sedation with cns 7056 (remimazolam)
03/20/2014US20140080811 Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non-Selective CA++ Activated ATP-Sensitive Cation Channels Regulatd by SUR1 Channels
03/20/2014US20140080807 Substituted indazole derivatives active as kinase inhibitors
03/20/2014US20140080803 Novel trpv3 modulators
03/20/2014US20140080801 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
03/20/2014US20140080798 Vegfr3 inhibitors
03/20/2014US20140080796 Acetyltanshinone iia (ata) as anticancer agent
03/20/2014US20140080788 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
03/20/2014US20140080787 Method for the Treatment of Neuropathies Associated with Charcot-Marie-Tooth 1A (CMT1A) Disease
03/20/2014US20140080784 Use of uridine and deoxyuridine to treat folate-responsive pathologies
03/20/2014US20140080783 Pharmaceutical combinations for treatment of specific cancers
03/20/2014US20140080779 Macrocyclic lactones and use thereof
03/20/2014US20140080771 Method for treating rhinitis and sinusitis by rhamnolipids
03/20/2014US20140080763 N-carboxyalkylauristatins and use thereof
03/20/2014US20140080762 Hyd1 peptides for relapsed cancer
03/20/2014US20140080757 Glucagon analogues
03/20/2014US20140080756 2,3-dihydro-1h-inden-1-yl-2,7-diazaspiro[3.5]nonane derivatives
03/20/2014US20140079812 Disulfide Chemotherapeutic Agents and Methods of Use Thereof
03/20/2014US20140079797 Skin formulation, preparation and uses thereof
03/20/2014US20140079787 Methods for treating hepatocellular carcinoma
03/20/2014US20140079784 Aerosolized lfa-1 antagonists for use in localized treatment of immune related disorders
03/20/2014US20140079774 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
03/20/2014US20140079772 Compositions and methods for the treatment of cancer
03/20/2014US20140079771 Methods and compositions for treatment of metabolic disorders
03/20/2014US20140079759 Fibrous polymer scaffolds having diametrically patterned polymer fibers
03/20/2014US20140079754 Microfabricated nanopore device for sustained release of therapeutic agent
03/20/2014US20140079743 Coatings of acrylamide-based copolymers
03/20/2014US20140079740 Oral transmucosal adminstration forms of s-ketamine
03/20/2014US20140079730 Composition comprising vlp and amyloid beta peptide
03/20/2014US20140079727 New endolysin plyp40
03/20/2014US20140079723 Therapeutic Compositions and Associated Methods
03/20/2014US20140079721 Compositions and methods for the diagnosis and treatment of tumor
03/20/2014US20140079706 Combination therapy of antibodies against human csf-1r and uses thereof
03/20/2014US20140079703 Combination therapies comprising anti-erbb3 agents
03/20/2014US20140079702 Antagonists of il-6 to raise albumin and/or lower crp
03/20/2014US20140079699 Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
03/20/2014US20140079695 Preventive agent for vasculitis
03/20/2014US20140079694 Cai-based systems and methods for the localized treatment of ocular and other diseases
03/20/2014US20140079693 Kinase inhibitors and methods of their use
03/20/2014US20140079690 Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
03/20/2014US20140079688 Methods for treating ophthalmic disorders, diseases and injuries
03/20/2014US20140079685 Method and composition for treating a serotonin receptor-mediated condition
03/20/2014US20140079667 Tetrazolones as inhibitors of fatty acid synthase
03/20/2014US20140079666 Pyrimidinone compounds and methods for preventing and treating influenza
03/20/2014US20140079665 Therapeutic anti-igf1r combinations
03/20/2014US20140079664 Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus
03/20/2014US20140079631 Anti-inflammatory particles
03/20/2014DE102009030418A1 Determining activity of kidneys when adrenal function is lost as result of e.g. destruction of nerve fibers and when adrenal function is restored by e.g. plant, corn oil and melon
03/19/2014EP2708231A1 Combined treatment with netrin-1 interfering drug and chemotherapeutic drug
03/19/2014EP2707028A1 c-KIT ANTIBODIES AND USES THEREOF
03/19/2014EP2706996A1 Combination of a statin and a taxane for the treatment of gastric cancer
03/19/2014CN103649756A Diagnosis of respiratory tract infectious disease using blood specimens
03/19/2014CN103648531A Method for prevention or treatment of metabolic syndrome
03/19/2014CN103648496A Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 1151